HIGHPASS BIO
Live / Registered — Registered (as of 13 Sept 2022)
What this means for you
Registered since 13 Sept 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88204562
- Registration number
- 6846903
- Mark type
- Stylized text
- Filed
- 25 Nov 2018
- Published for opposition
- 14 May 2019
- Registered
- 13 Sept 2022
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical products development; Research and development in the field of oncology; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development of vaccines and medicines; Research and development services in the field of antibodies; Research in the field of oncology; Research on the subject of pharmaceuticals; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Bacteriological research; Biochemical research and development; Biological research; Biomedical research services; Biotechnology research; Chemical, biochemical, biological and bacteriological research and analysis; Clinical research in the field of oncology; Compiling data for research purposes in the field of medical science and medical consultancy; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Development of pharmaceutical preparations and medicines; Laboratory research in the field of oncology; Laboratory research services relating to pharmaceuticals; Medical research; Medical and scientific research in the field of oncology; Medical and scientific research information in the field of cancer; Medical and scientific research in the field of cancer treatment and diagnosis; Medical research services in the field of cancer; Pharmaceutical research and development; Pharmaceutical research services; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Providing medical research and scientific research information in the field of oncology via the Internet; Providing medical testing services and information in the field of cancer research and disease classification; Scientific research; Scientific research and development; Scientific research consulting in the field of oncology; Scientific research for medical purposes in the area of cancerous diseases; Scientific research for medical purposes in the field of cancer; Stem cell research services; Technical research in the field of pharmaceutical studies; Testing of pharmaceuticals; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy
Owner
- ElevateBio, LLC, Cambridge, MA, US
- ElevateBio, LLC, Cambridge, MA, US
- ElevateBio, LLC, Cambridge, MA, US
Prosecution history
- 13 Sept 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 13 Sept 2022 — REGISTERED-PRINCIPAL REGISTER
- 10 Aug 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 09 Aug 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 08 Jul 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 05 Jul 2022 — USE AMENDMENT FILED
- 05 Jul 2022 — TEAS STATEMENT OF USE RECEIVED
- 08 Jan 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Jan 2022 — SOU EXTENSION 5 GRANTED
- 04 Jan 2022 — SOU EXTENSION 5 FILED
- 04 Jan 2022 — SOU TEAS EXTENSION RECEIVED
- 07 Jul 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Jul 2021 — SOU EXTENSION 4 GRANTED
- 05 Jul 2021 — SOU EXTENSION 4 FILED
- 05 Jul 2021 — SOU TEAS EXTENSION RECEIVED